These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21047993)

  • 1. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
    Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
    Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death receptor 4 variants and colorectal cancer risk.
    Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
    Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
    Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
    Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population.
    Xiong F; Wu C; Bi X; Yu D; Huang L; Xu J; Zhang T; Zhai K; Chang J; Tan W; Cai J; Lin D
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1855-61. PubMed ID: 20530476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
    Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
    Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk.
    Hoeft B; Linseisen J; Beckmann L; Müller-Decker K; Canzian F; Hüsing A; Kaaks R; Vogel U; Jakobsen MU; Overvad K; Hansen RD; Knüppel S; Boeing H; Trichopoulou A; Koumantaki Y; Trichopoulos D; Berrino F; Palli D; Panico S; Tumino R; Bueno-de-Mesquita HB; van Duijnhoven FJ; van Gils CH; Peeters PH; Dumeaux V; Lund E; Huerta Castaño JM; Muñoz X; Rodriguez L; Barricarte A; Manjer J; Jirström K; Van Guelpen B; Hallmans G; Spencer EA; Crowe FL; Khaw KT; Wareham N; Morois S; Boutron-Ruault MC; Clavel-Chapelon F; Chajes V; Jenab M; Boffetta P; Vineis P; Mouw T; Norat T; Riboli E; Nieters A
    Carcinogenesis; 2010 Mar; 31(3):466-72. PubMed ID: 20042636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
    Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.
    Probst-Hensch NM; Sun CL; Van Den Berg D; Ceschi M; Koh WP; Yu MC
    Carcinogenesis; 2006 Dec; 27(12):2475-82. PubMed ID: 16829689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals.
    El Awady MK; Karim AM; Hanna LS; El Husseiny LA; El Sahar M; Menem HA; Meguid NA
    Cancer Biomark; 2009; 5(6):233-40. PubMed ID: 20037199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
    Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
    Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer.
    Koushik A; Kraft P; Fuchs CS; Hankinson SE; Willett WC; Giovannucci EL; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2408-17. PubMed ID: 17164363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
    Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The joint association of REST and NFKB1 polymorphisms on the risk of colorectal cancer.
    Yu Y; Liu H; Jin M; Zhang M; Pan Y; Zhang S; Li Q; Chen K
    Ann Hum Genet; 2012 Jul; 76(4):269-76. PubMed ID: 22530801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.